Gynecologic Oncology Research

The division of Gynecologic Oncology at New York University consists of four board-certified experts in gynecologic cancers. While providing expert care, including the surgical and medical treatment of gynecologic malignancies, we also have National Institutes of Health (NIH)-sponsored clinical and basic research to improve women’s healthcare.

Our division participates in Gynecologic Oncology Group (GOG) clinical research trials evaluating new and novel treatment regimen for all gynecologic malignancies. In addition, we coordinate the National Ovarian Cancer Early Detection Program which combines genetics, ultrasound, and gynecologic oncology and is committed to the establishment of effective means for the accurate detection of early stage ovarian cancer especially in the high risk population. We also have National Cancer Institute (NCI) support for our pioneering research on the use of contrast sonography for the detection of early stage ovarian cancer.

Additionally our basic science laboratory focuses on the molecular and biochemical regulation of ovarian and endometrial metastasis.